Nautilus Biotechnolgy (NAUT)

• Market cap: $92.1M
• 1 day: -6.62%
• 5 days: -5.55%
• 1 month: -26.97%
• 3 months: -63.49%
• 6 months: -73.45%
• Year to date: -56.79%
• 1 year: -70.67%
• 5 years: -93.01%
• 10 years: -93.01%
• Sector: Healthcare
• Industry: Biotechnology

About: Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Employees: 155

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

53% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 17

36% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 11

4% more funds holding

Funds holding: 83 [Q3] → 86 (+3) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]

0.32% less ownership

Funds ownership: 51.18% [Q3] → 50.86% (-0.32%) [Q4]

41% less capital invested

Capital invested by funds: $183M [Q3] → $107M (-$75.7M) [Q4]